Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / GENOMIC BIOTECH
-
Total 13F shares
-
5,392,923
-
Share change
-
-88,687
-
Total reported value
-
$106,987,811
-
Price per share
-
$19.85
-
Number of holders
-
57
-
Value change
-
-$2,160,710
-
Number of buys
-
28
-
Number of sells
-
32
Institutional Holders of GLOBAL X FDS - GENOMIC BIOTECH (GNOM) as of Q4 2021
As of 31 Dec 2021,
GLOBAL X FDS - GENOMIC BIOTECH (GNOM) was held by
57 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
5,392,923 shares.
The largest 10 holders included
Mirae Asset Global Investments Co., Ltd., PNC Financial Services Group, Inc., Private Advisor Group, LLC, UBS Group AG, McGuire Investment Group, LLC, Change Path, LLC, LPL Financial LLC, Banco Santander, S.A., Jaffetilchin Investment Partners, LLC, and HighTower Advisors, LLC.
This page lists
58
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.